FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1858260015> ?p ?o ?g. }

• W1858260015 endingPage "27793" @default.
• W1858260015 startingPage "27778" @default.
• W1858260015 abstract "// Ran Duan 1, 5 , Lei Han 2, 3, 4, 5 , Qixue Wang 2, 3, 4, 5 , Jianwei Wei 2, 3, 4, 5 , Luyue Chen 2, 3, 4, 5 , Jianning Zhang 3, 4, 5 , Chunsheng Kang 2, 3, 4, 5 , Lei Wang 1, 5, 6 1 Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing, China 2 Laboratory of Neuro-Oncology, Tianjin Neurological Institute, Tianjin, China 3 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China 4 Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin, China 5 Chinese Glioma Cooperative Group (CGCG), Beijing, China 6 China National Clinical Research Center for Neurological Diseases, Beijing, China Correspondence to: Lei Wang, e-mail: wangleitiantan@163.com Chunsheng Kang, e-mail: kang97061@gmail.com Keywords: Homeobox (HOX) gene, HOXA13, glioma, SMAD, epithelial-to-mesenchymal transition (EMT) Received: March 21, 2015      Accepted: July 20, 2015      Published: July 31, 2015 ABSTRACT Homeobox (HOX) genes, including HOXA13, are involved in human cancer. We found that HOXA13 expression was associated with glioma grade and prognosis. Bioinformatics analysis revealed that most of the HOXA13-associated genes were enriched in cancer-related signaling pathways and mainly involved in the regulation of transcription. We transfected four glioma cell lines with Lenti-si HOXA13. HOXA13 increased cell proliferation and invasion and inhibited apoptosis. HOXA13 decreased β-catenin, phospho-SMAD2, and phospho-SMAD3 in the nucleus and increased phospho-β-catenin in the cytoplasm. Furthermore, downregulation of HOXA13 in orthotopic tumors decreased tumor growth. We suggest that HOXA13 promotes glioma progression in part via Wnt- and TGF-β-induced EMT and is a potential diagnostic biomarker for glioblastoma and an independent prognostic factor in high-grade glioma." @default.
• W1858260015 created "2016-06-24" @default.
• W1858260015 creator A5006630986 @default.
• W1858260015 creator A5011724071 @default.
• W1858260015 creator A5016196534 @default.
• W1858260015 creator A5020732815 @default.
• W1858260015 creator A5034396597 @default.
• W1858260015 creator A5039882839 @default.
• W1858260015 creator A5060461941 @default.
• W1858260015 creator A5073216396 @default.
• W1858260015 date "2015-07-31" @default.
• W1858260015 modified "2023-10-01" @default.
• W1858260015 title "HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways" @default.
• W1858260015 cites W1500090790 @default.
• W1858260015 cites W1528939398 @default.
• W1858260015 cites W1786924797 @default.
• W1858260015 cites W1964081206 @default.
• W1858260015 cites W1964348356 @default.
• W1858260015 cites W1964794638 @default.
• W1858260015 cites W1980956240 @default.
• W1858260015 cites W1990684688 @default.
• W1858260015 cites W1991575388 @default.
• W1858260015 cites W2000476637 @default.
• W1858260015 cites W2004568767 @default.
• W1858260015 cites W2006419043 @default.
• W1858260015 cites W2006788765 @default.
• W1858260015 cites W2008323939 @default.
• W1858260015 cites W2030048096 @default.
• W1858260015 cites W2042524329 @default.
• W1858260015 cites W2053028621 @default.
• W1858260015 cites W2057459511 @default.
• W1858260015 cites W2072870454 @default.
• W1858260015 cites W2074214911 @default.
• W1858260015 cites W2079360110 @default.
• W1858260015 cites W2086254436 @default.
• W1858260015 cites W2086323442 @default.
• W1858260015 cites W2095605427 @default.
• W1858260015 cites W2100206806 @default.
• W1858260015 cites W2105207670 @default.
• W1858260015 cites W2114622916 @default.
• W1858260015 cites W2121625674 @default.
• W1858260015 cites W2124288132 @default.
• W1858260015 cites W2126059322 @default.
• W1858260015 cites W2134251292 @default.
• W1858260015 cites W2142647376 @default.
• W1858260015 cites W2152134406 @default.
• W1858260015 cites W2154568166 @default.
• W1858260015 cites W2169236261 @default.
• W1858260015 doi "https://doi.org/10.18632/oncotarget.4813" @default.
• W1858260015 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4695025" @default.
• W1858260015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26356815" @default.
• W1858260015 hasPublicationYear "2015" @default.
• W1858260015 type Work @default.
• W1858260015 sameAs 1858260015 @default.
• W1858260015 citedByCount "80" @default.
• W1858260015 countsByYear W18582600152016 @default.
• W1858260015 countsByYear W18582600152017 @default.
• W1858260015 countsByYear W18582600152018 @default.
• W1858260015 countsByYear W18582600152019 @default.
• W1858260015 countsByYear W18582600152020 @default.
• W1858260015 countsByYear W18582600152021 @default.
• W1858260015 countsByYear W18582600152022 @default.
• W1858260015 countsByYear W18582600152023 @default.
• W1858260015 crossrefType "journal-article" @default.
• W1858260015 hasAuthorship W1858260015A5006630986 @default.
• W1858260015 hasAuthorship W1858260015A5011724071 @default.
• W1858260015 hasAuthorship W1858260015A5016196534 @default.
• W1858260015 hasAuthorship W1858260015A5020732815 @default.
• W1858260015 hasAuthorship W1858260015A5034396597 @default.
• W1858260015 hasAuthorship W1858260015A5039882839 @default.
• W1858260015 hasAuthorship W1858260015A5060461941 @default.
• W1858260015 hasAuthorship W1858260015A5073216396 @default.
• W1858260015 hasBestOaLocation W18582600151 @default.
• W1858260015 hasConcept C104317684 @default.
• W1858260015 hasConcept C121587040 @default.
• W1858260015 hasConcept C121608353 @default.
• W1858260015 hasConcept C126322002 @default.
• W1858260015 hasConcept C137620995 @default.
• W1858260015 hasConcept C143998085 @default.
• W1858260015 hasConcept C2778227246 @default.
• W1858260015 hasConcept C2779013556 @default.
• W1858260015 hasConcept C502942594 @default.
• W1858260015 hasConcept C54355233 @default.
• W1858260015 hasConcept C60644358 @default.
• W1858260015 hasConcept C62478195 @default.
• W1858260015 hasConcept C71924100 @default.
• W1858260015 hasConcept C76419328 @default.
• W1858260015 hasConcept C86339819 @default.
• W1858260015 hasConcept C86803240 @default.
• W1858260015 hasConceptScore W1858260015C104317684 @default.
• W1858260015 hasConceptScore W1858260015C121587040 @default.
• W1858260015 hasConceptScore W1858260015C121608353 @default.
• W1858260015 hasConceptScore W1858260015C126322002 @default.
• W1858260015 hasConceptScore W1858260015C137620995 @default.
• W1858260015 hasConceptScore W1858260015C143998085 @default.
• W1858260015 hasConceptScore W1858260015C2778227246 @default.
• W1858260015 hasConceptScore W1858260015C2779013556 @default.
• W1858260015 hasConceptScore W1858260015C502942594 @default.

• next